Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Biopsy Punch Market Research Report 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Biopsy Punch Industry
  • 1.7 COVID-19 Impact: Biopsy Punch Market Trends
  • 2 Global Biopsy Punch Quarterly Market Size Analysis

    • 2.1 Biopsy Punch Business Impact Assessment - COVID-19
      • 2.1.1 Global Biopsy Punch Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Biopsy Punch Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Biopsy Punch Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Biopsy Punch Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Biopsy Punch Market
    • 3.4 Key Players Biopsy Punch Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Biopsy Punch Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Reusable Biopsy Punch
      • 1.4.2 Disposable Biopsy Punch
    • 4.2 By Type, Global Biopsy Punch Market Size, 2019-2021

    5 Impact of Covid-19 on Biopsy Punch Segments, By Application

    • 5.1 Overview
      • 5.5.1 Dermatology
      • 5.5.2 Cosmetic procedures
      • 5.5.3 Lab
      • 5.5.4 Others
    • 5.2 By Application, Global Biopsy Punch Market Size, 2019-2021
      • 5.2.1 By Application, Global Biopsy Punch Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 C. R. Bard
      • 7.1.1 C. R. Bard Business Overview
      • 7.1.2 C. R. Bard Biopsy Punch Quarterly Revenue, 2020
      • 7.1.3 C. R. Bard Biopsy Punch Product Introduction
      • 7.1.4 C. R. Bard Response to COVID-19 and Related Developments
    • 7.2 Acuderm
      • 7.2.1 Acuderm Business Overview
      • 7.2.2 Acuderm Biopsy Punch Quarterly Revenue, 2020
      • 7.2.3 Acuderm Biopsy Punch Product Introduction
      • 7.2.4 Acuderm Response to COVID-19 and Related Developments
    • 7.3 Kai Industries
      • 7.3.1 Kai Industries Business Overview
      • 7.3.2 Kai Industries Biopsy Punch Quarterly Revenue, 2020
      • 7.3.3 Kai Industries Biopsy Punch Product Introduction
      • 7.3.4 Kai Industries Response to COVID-19 and Related Developments
    • 7.4 MedGyn
      • 7.4.1 MedGyn Business Overview
      • 7.4.2 MedGyn Biopsy Punch Quarterly Revenue, 2020
      • 7.4.3 MedGyn Biopsy Punch Product Introduction
      • 7.4.4 MedGyn Response to COVID-19 and Related Developments
    • 7.5 Bako
      • 7.5.1 Bako Business Overview
      • 7.5.2 Bako Biopsy Punch Quarterly Revenue, 2020
      • 7.5.3 Bako Biopsy Punch Product Introduction
      • 7.5.4 Bako Response to COVID-19 and Related Developments
    • 7.6 Integra LifeSciences
      • 7.6.1 Integra LifeSciences Business Overview
      • 7.6.2 Integra LifeSciences Biopsy Punch Quarterly Revenue, 2020
      • 7.6.3 Integra LifeSciences Biopsy Punch Product Introduction
      • 7.6.4 Integra LifeSciences Response to COVID-19 and Related Developments
    • 7.7 Robbins Instruments
      • 7.7.1 Robbins Instruments Business Overview
      • 7.7.2 Robbins Instruments Biopsy Punch Quarterly Revenue, 2020
      • 7.7.3 Robbins Instruments Biopsy Punch Product Introduction
      • 7.7.4 Robbins Instruments Response to COVID-19 and Related Developments
    • 7.8 Sklar Surgical Instruments
      • 7.8.1 Sklar Surgical Instruments Business Overview
      • 7.8.2 Sklar Surgical Instruments Biopsy Punch Quarterly Revenue, 2020
      • 7.8.3 Sklar Surgical Instruments Biopsy Punch Product Introduction
      • 7.8.4 Sklar Surgical Instruments Response to COVID-19 and Related Developments
    • 7.9 CooperSurgical
      • 7.9.1 CooperSurgical Business Overview
      • 7.9.2 CooperSurgical Biopsy Punch Quarterly Revenue, 2020
      • 7.9.3 CooperSurgical Biopsy Punch Product Introduction
      • 7.9.4 CooperSurgical Response to COVID-19 and Related Developments
    • 7.10 BR Surgical
      • 7.10.1 BR Surgical Business Overview
      • 7.10.2 BR Surgical Biopsy Punch Quarterly Revenue, 2020
      • 7.10.3 BR Surgical Biopsy Punch Product Introduction
      • 7.10.4 BR Surgical Response to COVID-19 and Related Developments
    • 7.11 G. HARTZELL & SON INSTRUMENT
      • 7.11.1 G. HARTZELL & SON INSTRUMENT Business Overview
      • 7.11.2 G. HARTZELL & SON INSTRUMENT Biopsy Punch Quarterly Revenue, 2020
      • 7.11.3 G. HARTZELL & SON INSTRUMENT Biopsy Punch Product Introduction
      • 7.11.4 G. HARTZELL & SON INSTRUMENT Response to COVID-19 and Related Developments
    • 7.12 Wallach Surgical Devices
      • 7.12.1 Wallach Surgical Devices Business Overview
      • 7.12.2 Wallach Surgical Devices Biopsy Punch Quarterly Revenue, 2020
      • 7.12.3 Wallach Surgical Devices Biopsy Punch Product Introduction
      • 7.12.4 Wallach Surgical Devices Response to COVID-19 and Related Developments
    • 7.13 Schuco
      • 7.13.1 Schuco Business Overview
      • 7.13.2 Schuco Biopsy Punch Quarterly Revenue, 2020
      • 7.13.3 Schuco Biopsy Punch Product Introduction
      • 7.13.4 Schuco Response to COVID-19 and Related Developments
    • 7.14 DTR Medical Ltd
      • 7.14.1 DTR Medical Ltd Business Overview
      • 7.14.2 DTR Medical Ltd Biopsy Punch Quarterly Revenue, 2020
      • 7.14.3 DTR Medical Ltd Biopsy Punch Product Introduction
      • 7.14.4 DTR Medical Ltd Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Biopsy Punch, including the following market information:
      Global Biopsy Punch Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biopsy Punch Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biopsy Punch Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biopsy Punch Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include C. R. Bard, Acuderm, Kai Industries, MedGyn, Bako, Integra LifeSciences, Robbins Instruments, Sklar Surgical Instruments, CooperSurgical, BR Surgical, G. HARTZELL & SON INSTRUMENT, Wallach Surgical Devices, Schuco, DTR Medical Ltd, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Reusable Biopsy Punch
      Disposable Biopsy Punch

      Based on the Application:
      Dermatology
      Cosmetic procedures
      Lab
      Others

      Buy now